Helping prisoners notify their partners about HIV exposure
Prison-Based HIV Partner Notification in Indonesia
['FUNDING_R01'] · UNIVERSITY OF ILLINOIS AT CHICAGO · NIH-11086543
This study is looking at a friendly way to help people in prison in Indonesia let their past partners know about possible HIV exposure, so they can get tested and treated quickly.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT CHICAGO (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-11086543 on ClinicalTrials.gov |
What this research studies
This research focuses on improving HIV testing and diagnosis among individuals who have been in contact with the virus, particularly in prison settings in Indonesia. It utilizes a method called Assisted Partner Notification (APN), where trained community health workers help inmates inform their former sexual and drug-using partners about potential HIV exposure. The study aims to evaluate the effectiveness of this approach in encouraging timely testing and treatment referrals for those at risk. By addressing the unique challenges faced by incarcerated individuals, the research seeks to enhance public health outcomes in the community.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals currently incarcerated in Indonesia who are diagnosed with HIV and have former partners at risk of exposure.
Not a fit: Patients who are not incarcerated or those who do not have a history of HIV exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of individuals tested for HIV and linked to care, ultimately reducing the spread of the virus.
How similar studies have performed: Previous studies have shown that Assisted Partner Notification can be effective in community settings, suggesting potential success in prison environments as well.
Where this research is happening
Chicago, UNITED STATES
- UNIVERSITY OF ILLINOIS AT CHICAGO — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CULBERT, GABRIEL JOHN — UNIVERSITY OF ILLINOIS AT CHICAGO
- Study coordinator: CULBERT, GABRIEL JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus